Synthetic Biology-Based Engineering Living Therapeutics for Antimicrobial Application

Area of Science:

• Synthetic Biology
• Microbiology
• Therapeutics

Background:

• Antimicrobial resistance (AMR) is a growing global threat, outpacing new antibiotic development.
• Emerging pathogenic superbugs pose significant risks to public health and the economy.
• Novel strategies are urgently needed to combat resistant microbial infections.

Purpose of the Study:

• To review recent advancements in engineering living therapeutics for antibacterial treatment using synthetic biology.
• To explore modifications of bacteriophages, microbes, and mammalian cells for targeted antimicrobial therapy.
• To discuss the advantages and challenges of these engineered living therapeutic approaches.

Main Methods:

• Engineering bacteriophages for targeted bacterial lysis.
• Modifying bacteria as therapeutic agents for pathogen elimination.
• Altering mammalian cells to detect and destroy pathogenic microorganisms.
• Utilizing synthetic biology principles for system design and component assembly.

Main Results:

• Engineered living therapeutics demonstrate potential for precise detection and eradication of pathogenic microbes.
• Synthetic biology enables the redesign of biological systems for specific antimicrobial functions.
• Various engineering approaches applied to phages, microbes, and mammalian cells show promise.
• Advantages include targeted action and potential to overcome existing resistance mechanisms.

Conclusions:

• Engineering living therapeutics via synthetic biology presents a promising innovative strategy against antimicrobial resistance.
• Further research and development are crucial to overcome challenges and realize the full potential of these approaches.
• This field holds significant promise for future antimicrobial therapies and combating superbug threats.